Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Ozmosis Research (Canada) | Researchclopedia

Back to institutions

Ozmosis Research (Canada)

Toronto, Ontariocompany

39

Works

1,148

Citations

14

h-index

Top Research Topics

Nuclear Structure and Function Cancer Genomics and Diagnostics Renal cell carcinoma treatment

Top Researchers

Amit M. Oza University Health Network

1,120 works55,532 citationsh-index: 102

Recent Research

631P Phase Ib expansion study of CX-5461 in patients with solid tumours and BRCA2 and/or PALB2 mutation

Pamela Soberanis Pina,Stéphanie Lheureux,et al.

20243 citations

PARP inhibition in cancer therapy

Ovarian cancer diagnosis and treatment

Pancreatic and Hepatic Oncology Research

Renal and related cancers

COVID-19 Clinical Research Studies

Cancer, Hypoxia, and Metabolism

Colorectal Cancer Treatments and Studies

Cancer Treatment and Pharmacology

Neuroblastoma Research and Treatments

Gregory R. Pond Ontario Institute for Cancer Research

928 works22,173 citationsh-index: 78

Fernando Camacho Parc Científic de la Universitat de València

266 works5,365 citationsh-index: 37

A. Gerson Greenburg

149 works3,417 citationsh-index: 27

Jane Liang White Pfizer (United States)

24 works2,993 citationsh-index: 17

Sareh Keshavarzi University of Toronto

172 works2,134 citationsh-index: 23

Phase II randomized multi-centre study of neoadjuvant olaparib in patients with platinum sensitive relapsed high grade serous ovarian cancer: The NEO trial.

Stéphanie Lheureux,Taymaa May,et al.

20241 citations

537P A phase I/II study of oral chk1 inhibitor LY2880070 in combination with low-dose gemcitabine in patients with advanced or metastatic ovarian cancer

W.H. Miller,A.F. Shields,et al.

20225 citations

743P A phase Ib dose escalation study of CD137 mAb agonist OC-001 as monotherapy in patients with advanced or metastatic cancer

W.H. Miller,D. Provencher,et al.

20221 citations

Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study

Patrick Cheung,Samir Patel,et al.

2021119 citations

Stereotactic Radiotherapy for Oligoprogression in Metastatic Kidney Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Prospective Phase II Multi-Centre Study

Pierre Cheung,S. Patel,et al.

20201 citations